japanese society of medical oncology

What japanese society of medical oncology does

The Japanese Society of Medical Oncology (JSMO, 公益社団法人日本臨床腫瘍学会) is a Tokyo-based Public Interest Incorporated Association founded in 1993 that functions as Japan's leading clinical oncology professional society. JSMO operates a multi-pronged platform serving medical oncologists, cancer researchers, medical students, residents, and the general public. Its core offerings include: (1) specialist certification — JSMO administers the cancer pharmacotherapy specialist (がん薬物療法専門医) qualification examination and accredits training facilities under Japan's New Specialist System; (2) education — annual academic meetings (JSMO2026, JSMO2027, Best of ASCO Japan), e-learning seminars running January to December, geriatric oncology workshops, and a young oncologist program delivered jointly with ASCO; (3) training infrastructure — the J Osler-Oncol. case registration system used by residents to log training cases (registration fee 13,000 yen); (4) publications and guidelines — including Annals of Oncology as official journal and clinical guidelines such as colorectal cancer genetic testing guidance; and (5) research support — including a 1 million yen-per-project Young Researcher Grant co-funded with the Kobayashi Foundation for Cancer Research. The society is governed by a board led by Chairman Hironobu Minami (南 博信) and operates across Education, Career Empowerment, Geriatric Oncology, and Student/Trainee working groups. JSMO collaborates internationally with ASCO (annual Young Oncologist Workshop) and KSMO (joint symposium) and domestically with the Japanese Society of Thyroid Surgery and Japan Association of Endocrine Surgeons on a Head and Neck Cancer Coordination Program including a patient registry.

As a non-profit professional society, JSMO is funded through membership dues (amounts not publicly disclosed), conference and seminar fees, certification and case registration fees, publication-related income, and donations (寄附). Its distribution model is direct to members via a member-exclusive portal containing abstract search, online journals, member data, and literature introductions. The society operates from Shiba Park Building 6F, 2-1-15 Shibakoen, Minato-ku, Tokyo.

Name

japanese society of medical oncology

Legal name

公益社団法人日本臨床腫場学会 (Public Interest Incorporated Association Japanese Society of Medical Oncology)

Website

https://jsmo.or.jp

Company type

Private

Founded year

1993

Operating status

Operating

Short description

The Japanese Society of Medical Oncology (JSMO) is a Tokyo-based public interest professional association founded in 1993 that certifies cancer pharmacotherapy specialists, runs annual conferences and e-learning programs, publishes clinical guidelines and the Annals of Oncology, and serves medical oncologists, researchers, medical students, and patients across Japan.

Ownership category

akta.pro rank

Product category

Professional Medical Society Services

NAICS

Professional and Management Development Training (611430), Colleges, Universities, and Professional Schools (611310), Scientific Research and Development Services (5417)

SIC

Services-Educational Services (8200), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYEDAAAPAA

Healthcare & Life Sciences

Education/Adult & Continuing Education/Industry-Specific Training (Healthcare, Tech, etc.)

SECONDARYEDAAALAC

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)

Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)

SECONDARYTHAHAJAB

Life Sciences & Biotechnology Congresses

Travel & Hospitality/MICE (Meetings, Incentives, Conferences & Exhibitions)/Association, Government & Academic Congresses

Keywords

• Clinical oncology
• Medical oncology
• Cancer pharmacotherapy certification
• Oncology professional education
• Cancer treatment guidelines

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels5 records

Core offering

JSMO is a Public Interest Incorporated Association that provides specialist certification in cancer pharmacotherapy, standardized residency training programs, e-learning educational seminars, annual academic conferences (JSMO series), clinical oncology guidelines, academic journal access (Annals of Oncology), and competitive research grants for young cancer researchers. Services are delivered to medical oncologists, residents, medical students, and certified training facilities across Japan.

Product overview

JSMO is a medical society organization (公益社団法人) focused on clinical oncology, not a technology product company. Their offerings consist of professional education programs (e-learning seminars, academic conferences), specialist certification systems (cancer pharmacotherapy specialist certification, medical oncology residency training), academic publications (online journals, guidelines, Annals of Oncology as official journal), clinical programs (head and neck cancer coordination program with patient registry), and research support (young researcher grants). These are membership-based professional services for medical oncologists and cancer researchers in Japan.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual Academic Meetings (学術集会)
• E-learning Educational Seminars (教育セミナー e-learning)
• Cancer Pharmacotherapy Specialist Certification System (がん薬物療法専門医制度)
• Medical Oncology Residency Program (腫瘍内科専門医プログラム)
• Clinical Oncology Publications and Guidelines (刊行物・ガイドライン)
• Online Journal Access (Annals of Oncology, ESMO Open)
• J Osler-Oncol. Case Registration System (J Osler-Oncol. 症例登録システム)
• JSMO/KFCR Young Researcher Grant (JSMO/KFCR 若手研究助成)

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Japanese Society of Thyroid SurgerycoreStrategic or Co-development PartnerCollaborative partnership for head and neck cancer treatment coordination. The three societies (JSMO, Japanese Society of Thyroid Surgery, Japan Association of Endocrine Surgeons) work together to promote team-based cancer care involving otolaryngology, head and neck surgery, oral surgery, radiation oncology, medical oncology, nursing, and pharmacy specialists.
• Japan Association of Endocrine SurgeonscoreStrategic or Co-development PartnerCollaborative partnership for head and neck cancer treatment coordination. The three societies work together to promote interdisciplinary team-based cancer care and education across specialties.
• Kobayashi Foundation for Cancer Research (KFCR)coreStrategic or Co-development PartnerJoint research grant program supporting young researchers in cancer pharmacotherapy. KFCR provides funding for JSMO's competitive research grants targeting researchers within 5 years of obtaining their doctorate degree.
• American Society of Clinical Oncology (ASCO)coreStrategic or Co-development PartnerJoint JSMO/ASCO Young Oncologist Workshop conducted annually to foster international collaboration and education for early-career oncologists.
• Korean Society of Medical Oncology (KSMO)minorStrategic or Co-development PartnerJoint symposium organized at annual meetings to promote collaboration between Japanese and Korean medical oncology societies.

Recent moves7 records

Expansion highlights5 records

Direct peers

• American Society of Clinical Oncology (ASCO): ASCO is the leading U.S. medical oncology society, running the annual ASCO meeting, publishing the Journal of Clinical Oncology, and certifying oncologists; JSMO explicitly partners with ASCO on the Young Oncologist Workshop and Best of ASCO Japan, making it the closest international counterpart.
• European Society for Medical Oncology (ESMO): ESMO is Europe's primary medical oncology society, publisher of Annals of Oncology and ESMO Open (both listed as JSMO-affiliated online journals); it sets clinical guidelines and runs major congresses, serving as JSMO's main European peer.
• Korean Society of Medical Oncology (KSMO): KSMO is Korea's national medical oncology society and JSMO's formal partner for a joint annual symposium; both serve medical oncologists, publish guidelines, and run national conferences in comparable East Asian healthcare systems.
• Japanese Cancer Association (JCA): JCA is Japan's leading general cancer research society, focused on basic and translational research; JSMO focuses on clinical oncology, but both serve overlapping Japanese cancer professionals and frequently cross-publish at each other's meetings.
• National Comprehensive Cancer Network (NCCN): NCCN develops widely used oncology clinical practice guidelines and runs educational programs for oncologists; JSMO's own guidelines and publications play a parallel role in Japan, making NCCN a functional peer despite different organizational forms.
• Japan Society of Clinical Oncology (JSCO): JSCO is another Japanese clinical oncology society focused on surgical and multidisciplinary cancer care; it overlaps with JSMO on Japanese oncology education and guidelines, particularly for multidisciplinary head and neck cancer coordination.
• European Society for Medical Oncology (ESMO) Open / Annals of Oncology: Listed as JSMO's official online journals, Annals of Oncology and ESMO Open are flagship ESMO publications; their hosting relationship makes ESMO's publishing arm a tightly coupled content peer for JSMO's research dissemination.

Regional players

• Chinese Society of Clinical Oncology (CSCO): CSCO is China's primary clinical oncology society, running the annual CSCO meeting and clinical guidelines for oncologists; it operates in the same Asian regulatory and demographic context as JSMO but is geographically distinct.

Broad incumbents

• Japanese Society of Internal Medicine (JSIM): JSIM is Japan's main internal medicine society and parent of multiple subspecialty boards including medical oncology; it sets the framework for the New Specialist System that JSMO's certification operates within, making it a structural peer.
• American Association for Cancer Research (AACR): AACR is a large U.S. cancer research organization publishing major journals and running the AACR Annual Meeting; it overlaps with JSMO on research dissemination and educational programming but is broader in scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/JSMO_official
• Facebookfacebook.com/jsmo.or.jp

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about japanese society of medical oncology